U.S. infectious disease expert Anthony Fauci said it would be clear whether a Covid-19 vaccine was safe and effective by early December, but that more widespread vaccination would not be likely until later in 2021.
Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict the eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample.
Many experts are convinced that Covid-19 can trigger the onset of diabetes – even in some adults and children who do not have the traditional risk factors.
The U.S. National Institutes of Health is launching a clinical trial of a combination of Gilead Sciences’ antiviral drug remdesivir (Vitrakvy) and hyperimmune intravenous immunoglobulin (hIVIG).
Three scientists will share the Nobel Prize for Medicine for their seminal discoveries that led to the identification of the Hepatitis C virus, a significant health problem across the globe that can lead to cirrhosis and liver cancer in patients.
President Donald Trump, under fire over his handling of the coronavirus epidemic, announced that the federal government would ship 150 million rapid tests to U.S. states and warned an increase in positive cases is likely in the days ahead.
The number of new Covid-19 cases in the United States rose two weeks in a row in 27 out of 50 states, with North Carolina and New Mexico both reporting increases above 50% last week, according to a Reuters analysis.
A top U.S. health official told a U.S. Senate committee that he expects Covid-19 vaccinations to take place over many months and that most Americans could be vaccinated by July 2021 at the latest.
The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the Covid-19 pandemic.
The U.S. National Institutes of Health launched a clinical trial of fostamatinib, currently used to treat a blood platelet-destroying autoimmune disorder, in patients hospitalized with severe Covid-19.